188 related articles for article (PubMed ID: 34117220)
1. PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53.
Wang W; Wei J; Zhang H; Zheng X; Zhou H; Luo Y; Yang J; Deng Q; Huang S; Fu Z
Cell Death Dis; 2021 Jun; 12(6):605. PubMed ID: 34117220
[TBL] [Abstract][Full Text] [Related]
2. PRDX2 removal inhibits the cell cycle and autophagy in colorectal cancer cells.
Zheng X; Wei J; Li W; Li X; Wang W; Guo J; Fu Z
Aging (Albany NY); 2020 Jul; 12(16):16390-16409. PubMed ID: 32692719
[TBL] [Abstract][Full Text] [Related]
3. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
[TBL] [Abstract][Full Text] [Related]
4. MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance.
Lu J; Li Y; Wu Y; Zhou S; Duan C; Dong Z; Kang T; Tang F
Theranostics; 2018; 8(19):5289-5306. PubMed ID: 30555547
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress.
Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
Mol Cell Biochem; 2014 Feb; 387(1-2):261-70. PubMed ID: 24234423
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
7. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
9. Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling.
Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
Cancer Lett; 2014 Feb; 343(2):190-9. PubMed ID: 24125860
[TBL] [Abstract][Full Text] [Related]
10. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
Peng L; Wang R; Shang J; Xiong Y; Fu Z
Oncotarget; 2017 Feb; 8(9):15057-15070. PubMed ID: 28125800
[TBL] [Abstract][Full Text] [Related]
11. Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer.
Zhang S; Fu Z; Wei J; Guo J; Liu M; Du K
Med Oncol; 2015 Jan; 32(1):414. PubMed ID: 25471788
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation.
Chen D; Li Y; Zhang X; Wu H; Wang Q; Cai J; Cui Y; Liu H; Lan P; Wang J; Yang Z; Wang L
Oncogene; 2019 Sep; 38(37):6429-6444. PubMed ID: 31332286
[TBL] [Abstract][Full Text] [Related]
13. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
14. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.
Wang R; Wei J; Zhang S; Wu X; Guo J; Liu M; Du K; Xu J; Peng L; Lv Z; You W; Xiong Y; Fu Z
Oncotarget; 2016 Dec; 7(52):86816-86828. PubMed ID: 27894099
[TBL] [Abstract][Full Text] [Related]
15. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
16. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
[TBL] [Abstract][Full Text] [Related]
17. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS
J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154
[TBL] [Abstract][Full Text] [Related]
18. Expression of circZNF609 is Down-Regulated in Colorectal Cancer Tissue and Promotes Apoptosis in Colorectal Cancer Cells by Upregulating p53.
Zhang X; Zhao Y; Kong P; Han M; Li B
Med Sci Monit; 2019 Aug; 25():5977-5985. PubMed ID: 31401644
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation.
Li Y; Yang D; Tian N; Zhang P; Zhu Y; Meng J; Feng M; Lu Y; Liu Q; Tong L; Hu L; Zhang L; Yang JY; Wu L; Tong X
J Biol Chem; 2019 Oct; 294(40):14745-14756. PubMed ID: 31409643
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1/MDM2-p53 signaling pathway.
Zhu X; Luo C; Lin K; Bu F; Ye F; Huang C; Luo H; Huang J; Zhu Z
Biosci Trends; 2020 May; 14(2):83-95. PubMed ID: 32132307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
